Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psoriasis and palmoplantar pustulosis: an endless debate?
Alexandra Maria Giovanna Brunasso, Cesare Massone
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. 7
Closed Access | Times Cited: 21

Showing 21 citing articles:

Similarity and difference between palmoplantar pustulosis and pustular psoriasis
Toshiyuki Yamamoto
The Journal of Dermatology (2021) Vol. 48, Iss. 6, pp. 750-760
Closed Access | Times Cited: 36
Recent advances in palmoplantar pustulosis
Alexandra Maria Giovanna Brunasso, Cesare Massone
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 35
Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis
Morgan Sussman, Anthony Napodano, Simo Huang, et al.
Medicina (2021) Vol. 57, Iss. 10, pp. 1004-1004
Open Access | Times Cited: 29
Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis
Toshiyuki Yamamoto
Clinical Drug Investigation (2019) Vol. 39, Iss. 3, pp. 241-252
Closed Access | Times Cited: 30
Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea
Dong Hyo Kim, Jin Yong Lee, Soo Ick Cho, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 6, pp. 650-650
Open Access | Times Cited: 15
Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)
Dagmar Wilsmann‐Theis, Selina Patt, Andreas Pinter, et al.
JAAD International (2024) Vol. 18, pp. 69-78
Open Access | Times Cited: 3
Efficacy of guselkumab in a subpopulation with pustulotic arthro‐osteitis through week 52: an exploratory analysis of a phase 3, randomized, double‐blind, placebo‐controlled study in Japanese patients with palmoplantar pustulosis
Toshiyuki Yamamoto, Koji Fukuda, Akimichi Morita, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 10, pp. 2318-2329
Open Access | Times Cited: 20
Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
Qingqing Xu, Xiaochen Wang, Anbo Yang, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 5165-5172
Open Access | Times Cited: 7
Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross‐sectional, multicentre study of 263 patients
Sezgi Sarıkaya Solak, Asude Kara Polat, Sevilay Kılıç, et al.
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 1, pp. 63-71
Closed Access | Times Cited: 15
Optimal treatments and outcome measures of palmoplantar pustulosis: A systematic review and network meta‐analysis‐based comparison of treatment efficacy
Takemichi Fukasawa, Takashi Yamashita, Atsushi Enomoto, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 2, pp. 281-288
Closed Access | Times Cited: 5
Geographic tongue: What is this disease?
Yasuhiro Horiuchi
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 12, pp. 1465-1467
Closed Access | Times Cited: 5
Effects of Cyclosporine on Palmoplantar Pustulosis and Serum Expression of IL-17, IL-23, and TNF-α
Xian‐Hua Jin, Xi Chen, Yan Mou, et al.
Dermatology and Therapy (2019) Vol. 9, Iss. 3, pp. 547-552
Open Access | Times Cited: 8
Lingua geographica: Welche Krankheit ist das?
Yasuhiro Horiuchi
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 12, pp. 1465-1468
Closed Access | Times Cited: 2
Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective
Toshiyuki Yamamoto
Clinical Pharmacology Advances and Applications (2021) Vol. Volume 13, pp. 135-143
Open Access | Times Cited: 4
Guselkumab - In Psoriasis and Beyond
Aditya Kumar Bubna, Vinayak Viplav
Dermatology Practical & Conceptual (2024), pp. e2024181-e2024181
Open Access
Rapid therapeutic response of palmoplantar pustulosis under biologic treatment with guselkumab
Sonja Duderstadt, Ulrike Raap, Nikolaos Patsinakidis
Dermatologic Therapy (2021) Vol. 34, Iss. 2
Open Access | Times Cited: 3
A Case Report of Improved Palmoplantar Pustulosis following Periodontal Treatment and Possible Association with Diminished Systemic Subclinical Inflammation
Akiko Yamashita, Tomomi Sano, Misaki Iwashita, et al.
Case Reports in Dermatological Medicine (2021) Vol. 2021, pp. 1-5
Open Access | Times Cited: 1
Successful Treatment of Refractory Palmoplantar Pustulosis with Guselkumab in a Real-world Setting: Case Series
Yong Jun Hong, Miri Kim
Daehan geonseon hakoeji (Online) (2023) Vol. 20, Iss. 2, pp. 70-74
Open Access
Pustulosis palmoplantar: características epidemiológicas, clínicas y genéticas de una serie de 41 casos
Lula María Nieto‐Benito, Ángel Manuel Rosell‐Díaz, Ana Mateos‐Mayo, et al.
Piel (2019) Vol. 34, Iss. 5, pp. 266-271
Closed Access
Berufsdermatologische Aspekte der Pustulosis palmoplantaris
Lara Obermeyer, Christoph Skudlik, Swen Malte John, et al.
Der Hautarzt (2020) Vol. 71, Iss. 9, pp. 699-704
Closed Access
Palmoplantar Pustulosis associated with Membranous Glomerulonephritis
Vishal Thakur, Jasmine Sethi, Debajyoti Chatterjee, et al.
Indian Dermatology Online Journal (2021) Vol. 12, Iss. 2, pp. 349-350
Open Access
Page 1

Scroll to top